[144] Nvidia Corp SEC Filing

Rhea-AI Filing Summary

Nvidia insider Form 144 filing indicates a proposed sale of 52,774 shares of common stock with an aggregate market value of $7,999,942. The sale is planned to be executed through Rockefeller Capital Management on the Nasdaq exchange around June 25, 2025.

The securities were originally acquired through stock options on August 12, 2004. The filing also discloses recent trading activity by the Rosemary and A Brooke Seawell Rev Trust, which sold three batches of Nvidia shares in June 2025:

• June 20: 55,282 shares for $7,999,885
• June 23: 55,681 shares for $7,999,892
• June 24: 54,467 shares for $7,999,956

This Form 144 represents approximately 0.0002% of Nvidia's 24.4 billion outstanding shares, indicating a relatively minor insider transaction in relation to the company's total float.

Positive

• None.

Negative

• Insider has sold significant holdings over past 3 months - approximately 165,430 shares worth ~$24 million in total through three separate transactions in June 2025
• Current proposed sale of 52,774 shares valued at ~$8 million continues the selling pattern

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Capital Management Two Embarcadero Center Suite 232 San Francisco CA 94111	52774	7999942.26	24400000000	06/25/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2004	Stock Options	NVDA			52774	02/12/2004	cash/check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Rosemary and A Brooke Seawell Rev Trust 2788 San Tomas Expressway Santa Clara CA 95051	NVIDIA	06/20/2025	55282	7999885.00
Rosemary and A Brooke Seawell Rev Trust 2788 San Tomas Expressway, Santa Clara CA 95051	NVIDIA	06/23/2025	55681	7999891.98
Rosemary and A Brooke Seawell Rev Trust 2788 San Tomas Expressway Santa Clara CA 95051	NVIDIA	06/24/2025	54467	7999955.57

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many NVDA shares are being sold according to the June 2025 Form 144 filing?

According to the Form 144 filing, 52,774 shares of NVDA common stock are proposed to be sold through Rockefeller Capital Management, with an aggregate market value of $7,999,942.26.

When did the NVDA insider originally acquire these shares being sold?

The shares were originally acquired on August 12, 2004 through stock options from NVDA, with the initial payment made on February 12, 2004 via cash/check.

What previous NVDA stock sales were made by the seller in the past 3 months?

The Rosemary and A Brooke Seawell Rev Trust made three recent sales: 55,282 shares on June 20, 2025 ($7,999,885.00), 55,681 shares on June 23, 2025 ($7,999,891.98), and 54,467 shares on June 24, 2025 ($7,999,955.57).

What is the total number of outstanding NVDA shares according to the June 2025 Form 144?

According to the Form 144 filing, NVDA has 24,400,000,000 shares outstanding as of the filing date.

Through which broker is the NVDA insider planning to sell their shares?

The shares are planned to be sold through Rockefeller Capital Management, located at Two Embarcadero Center Suite 232, San Francisco CA 94111.